Author

Tamer M. Ibrahim

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Drug repurposing and African natural product screening, targeting the Parkinson‘s-associated LRRK2 G2019S mutant kinase using molecular docking and molecular dynamics approaches

The G2019S mutation in leucine-rich repeat kinase 2 (LRRK2) is the most prevalent genetic contributor to Parkinson’s disease and is associated with increased kinase activity. Targeting this mutation remains a key therapeutic strategy; however, structure-guided identification of repurposable inhibitors remains limited....

Omnia Saeed, Martina B. William, Mohamed Salama et al. · Scientific Reports · 0 citations

Jul 2026

Identification of novel pyrazolines and isoxazolines as antileishmanial agents via a potential antifolate mechanism: synthesis, biological evaluation, and in silico studies.

Based on its superior potency, high selectivity, and stable target binding in silico, the S-enantiomer of compound 1g represents a promising lead for further antileishmanial development.

Menna Desouky, Menna S. Hany, Ahmed R Elaraby et al. · Bioorganic chemistry (Print) · 0 citations